Arcmont and apoBank’s Financing The Investment in Smile Eyes Group

Ashurst advised certain funds managed by Arcmont Asset Management Limited and Deutsche Apotheker- und Ärztebank eG as lenders on the financing of the investment in Smile Eyes Group. GLNS has advised the founders and managing directors of Smile Eyes Group, Dres. Wiltfang and Bechmann.

The investment is structured as a partnership between Trilantic Europe, the two co-founders of Smile Eyes, Dr Martin Bechmann and Dr Rainer Wiltfang, and the management team. Arcmont acted as senior lender and apoBank as super senior lender.

Smile Eyes is a leading player in the German ophthalmology market with headquarters in Munich. The company stands for eye laser and lens surgery at the highest medical level and has a comprehensive service offering in the field of ophthalmology in various metropolitan regions in Germany.

Arcmont is a market-leading asset manager, providing flexible capital solutions to a wide range of businesses in Europe. Established in 2011 and previously part of BlueBay Asset Management, Arcmont is now an independent asset management firm managing approximately €17 billion of assets for institutional investors globally. Ashurst advises Arcmont and apoBank regularly in connection with the financing of leveraged buyouts.

Trilantic Europe is a pan-European private equity firm focusing on mid-market transactions in Europe. Trilantic’s sectors of focus are healthcare, consumer & leisure, industrials, TMT, and business services.

The Ashurst team advising Arcmont was led by partner Anne Grewlich (Picture) and counsel Sabrina Bremer. They were assisted by counsel Gabrielle Metherall, senior associate Emilie Veyran-Müller, senior transaction manager Carina Gläßl (all Global Loans) and transaction lawyer Isabelle Renninger (Banking & Finance, all Frankfurt).

The Ashurst team advising apoBank was led by partner Dr Matthias Weissinger (Banking & Finance, Munich).

The GLNS team included Partners Ludger Schult (Private Equity/M&A), Andreas Scheidle (Taxes) and Anselm Lenhard (Finance) and Associate Jennifer Blümlein (Private Equity/M&A).

Involved fees earner: Sabrina Bremer – Ashurst; Emilie Veyran-Müller – Ashurst; Anne Grewlich – Ashurst; Gabrielle Metherall – Ashurst; Matthias Weissinger – Ashurst; Jennifer Blümlein – GLNS; Anselm Lenhard – GLNS; Andreas Scheidle – GLNS; Ludger Schult – GLNS;

Law Firms: Ashurst; GLNS;

Clients: Arcmont Asset Management Limited; Deutsche Apotheker- und Ärztebank (apoBank); Martin Bechmann; Rainer Wiltfang;

Author: Federica Tiefenthaler